ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ILMN Illumina Inc

118.28
-5.71 (-4.61%)
May 03 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 2,987,106
Bid Price 117.85
Ask Price 119.95
News (1)
Day High 127.745

Low
89.00

52 Week Range

High
213.91

Day Low 117.67
Company Name Stock Ticker Symbol Market Type
Illumina Inc ILMN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-5.71 -4.61% 118.28 20:00:00
Open Price Low Price High Price Close Price Prev Close
127.08 117.67 127.745 117.93 123.99
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
52,877 2,987,106 $ 120.89 $ 361,104,583 - 89.00 - 213.91
Last Trade Time Type Quantity Stock Price Currency
19:58:57 1 $ 119.00 USD

Illumina (ILMN) Options Flow Summary

Overall Flow

Bearish

Net Premium

-647k

Calls / Puts

27.27%

Buys / Sells

40.00%

OTM / ITM

133.33%

Sweeps Ratio

0.00%

Illumina Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
18.74B 158.90M - 4.5B -1.16B -7.31 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Illumina News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ILMN Message Board. Create One! See More Posts on ILMN Message Board See More Message Board Posts

Historical ILMN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week119.65127.89117.67123.851,180,899-1.37-1.15%
1 Month125.05135.26115.73123.851,374,976-6.77-5.41%
3 Months143.20147.6999115.73131.891,611,266-24.92-17.40%
6 Months114.96148.1989.00123.582,136,7783.322.89%
1 Year195.96213.9189.00143.201,865,525-77.68-39.64%
3 Years393.48526.0089.00217.811,376,906-275.20-69.94%
5 Years315.74555.7789.00257.641,278,468-197.46-62.54%

Illumina Description

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Your Recent History

Delayed Upgrade Clock